FoxO1 expression is downregulated in the pulmonary vasculature and PASMCs of patients with PAH, and reconstitution of FoxO1 activity reverses vascular remodeling and right ventricular hypertrophy in vitro (54). The gene discussed is FOXO1; the disease is Right ventricular hypertrophy.